Skip to main content

Advertisement

Fig. 2 | Molecular Cancer

Fig. 2

From: Identification of the dopamine transporter SLC6A3 as a biomarker for patients with renal cell carcinoma

Fig. 2

The expression of 14 target mRNAs in renal cell carcinoma (red bars) and normal renal (green bars) tissue was validated using quantitative real-time PCR; the expression levels were normalized using ACTB and TBP as reference genes. Significant overexpression of SLC6A3, NPTX2, TFAIP6, NDUFA4L2, ENPP3, FABP6 and SPINK13 mRNA in renal cell carcinoma was confirmed, whereas FXYD4, SLC12A1, KNG1, NPHS2, SLC13A3, GCGR and PLG mRNA levels were downregulated (all p < 0.001)

Back to article page